Medizia Biotech is a trusted third party manufacturer of Cytarabine Injection BP 1000MG/10ML, offering high-quality oncology formulations manufactured in WHO-GMP compliant facilities. Cytarabine is a widely prescribed anti-cancer chemotherapy injection used in the treatment of Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Chronic Myeloid Leukemia (CML) blast crisis, and other hematological malignancies. We provide reliable manufacturing solutions for pharmaceutical companies, hospitals, institutional suppliers, exporters, and distributors across India and international markets.
As a leading Cytarabine Injection manufacturer in India, Medizia Biotech offers comprehensive third party manufacturing, contract manufacturing, private labeling, custom packaging, and bulk supply services. Our advanced manufacturing processes ensure consistent quality, product stability, regulatory compliance, and timely delivery. We support startups as well as established pharmaceutical companies with low MOQ, ready-to-launch brands, and customized packaging to help expand their oncology portfolio.
Whether you are looking for a Cytarabine Injection supplier, exporter, wholesale manufacturer, or contract manufacturing partner, Medizia Biotech provides cost-effective and dependable solutions backed by stringent quality assurance and professional customer support.
Cytarabine Injection BP 100MG/1ML, Cytarabine Injection Manufacturer, Cytarabine Injection Supplier, Third Party Manufacturing, Contract Manufacturing, Oncology Injection Manufacturer, Anti Cancer Injection, Leukemia Treatment Injection, Pharma Manufacturing Company, Pharma Franchise, Bulk Supplier, Exporter, Private Label Manufacturing, WHO GMP Manufacturer, Medizia Biotech.